Results 231 to 240 of about 36,896 (275)

Efficacy and safety of goniotomy and gonioscopy-assisted transluminal trabeculotomy for exfoliation glaucoma: a systematic review and single-arm meta-analysis. [PDF]

Front Med (Lausanne)
Li W, Geng Y, Shi K, Tang G, Yan X, Li Y, Zhang T, Lu J, Wang S, Zhang H.   +9 more
europepmc   +1 more source

Complement, Inflammasome, and Microglial Crosstalk in Glaucoma: From Neurodegeneration to Immune-Based Precision Therapy. [PDF]

Life (Basel)
Chen TY, Wu N, Sun X.
europepmc   +1 more source

Stem cell-based approaches for glaucoma treatment: a mini review. [PDF]

Open Life Sci
Yang X, Guo H, Wang S, Lu S, Wang J, Yuan X.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

New perspectives on target intraocular pressure

Survey of Ophthalmology, 2014
The evidence in support of intraocular pressure (IOP) lowering to reduce risk of glaucoma onset or progression is strong, although the amount and quality of IOP reduction is less well defined. The concept of a target IOP includes a percentage reduction, calculated IOP, or a predetermined IOP figure or range.
Clement, Colin I, Bhartiya, Shibal, Shaarawy, Tarek   +2 more
openaire   +5 more sources

Canadian perspectives in glaucoma management: setting target intraocular pressure range

Canadian Journal of Ophthalmology, 2003
There is an abundance of evidence from recent randomized clinical trials showing that lowering the IOP is beneficial to the optic nerve and visual field. Setting and achieving a target IOP range is in keeping with evidence-based medicine. The benefits of reaching this target must be weighed against the risks of the treatment itself.
Karim F, Damji, Rama, Behki, Lan, Wang
openaire   +4 more sources

On the optimal values of «target» intraocular pressure

National Journal glaucoma, 2022
   Current statistics show that glaucoma is the main cause of irreversible blindness worldwide. This fact generates continued interest in the search for new methods of rapid and accurate diagnosis of the disease. Presently, reducing the level of intra-ocular pressure (IOP) is the only proven strategy for slowing the progression of glaucomatous optic ...
M. D. Kats, A. V. Kuroyedov
openaire   +1 more source

Achieving low target intraocular pressures in severe glaucoma

European Journal of Ophthalmology, 2020
Purpose: This study aimed to assess details of therapy required to achieve an intraocular pressure (IOP) of ⩽12 mmHg in patients with severe glaucoma of different etiologies. Methods: Patients with a follow-up of at least 1 year, who fulfilled inclusion criteria were selected, and data analyzed with respect to baseline IOP, number of medications, and ...
Gazella Bruce Warjri, Talvir Sidhu, Azmira Kishan, Aswini Kumar Behera, Jyoti Shakrawal, Harathy Selvan, Tanuj Dada, Veena Pandey, Ramanjit Sihota   +8 more
openaire   +2 more sources

Targeting glaucoma beyond intraocular pressure

Expert Review of Ophthalmology, 2010
Primary open-angle glaucoma, as the most prevalent form of glaucoma, is a complex inherited disorder that affects more than 30 million individuals worldwide. It has become increasingly clear that genetic as well as environmental factors have an impact on the development of this disorder.
Bernd Rautenstrauss, Christian Mardin
openaire   +1 more source

TARGET INTRAOCULAR PRESSURE IN GLAUCOMA MANAGEMENT

Ophthalmology Clinics of North America, 2000
Not long ago in ophthalmology's history, elevated intraocular pressure (IOP) and glaucoma were synonymous: any elevation of IOP was considered glaucoma, and conversely, glaucoma was considered to be caused exclusively by pressure-related damage to the optic nerve head in eyes with elevated IOP.
T REALINI, R FECHTNER
openaire   +1 more source